MedAvail Holdings Inc (MDVLQ)

About

MYOS Corporation is an early development-stage biotherapeutics and bionutritional products company. The Company is focused on the discovery, development and commercialization of therapeutic products, nutritional supplements, functional foods and other technologies for muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. The Company is continuing to develop additional channels for distributing its products in other markets. The Company earns revenues from the distribution of MYO-T12, its platform dietary supplement product. MYOS currently has two commercial products: MYO-T12, which is branded under the MYO-X name, and distributed by MHP, and Cenegenics Muscle Formula, which is a private-label product distributed by Cenegenics.